[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Mass loss of trust", "description": "Is there a crisis of trust?\n\nhttps://ourworldindata.org/coronavirus\n\nJohn's free textbooks\n\nDownload my two comprehensive but free educational text books or make a donation to the campbellteaching project using this link: http://159.69.48.3Russia\n\nhttps://www.youtube.com/watch?v=ijgNJpUes4Y\n\nhttps://www.dailymail.co.uk/news/article-10084049/Video-showing-Putin-coughing-meeting-emerges-forced-deny-having-Covid-19.html\n\nInfections, + 29,409\n\nDeaths, + 973 = 217,000\n\nDelta variant\n\nVaccine hesitancy\n\nFirst dose, 33%\n\nRolled out before trials\n\nProblem is not that bad\n\nGovernment had won the war on covid-19\n\nMr. Putin pulls out of G20 meeting due to 'diary clash'\n\nTwo doses of Sputnik V\n\nITU, 8,000 patients\n\nPatients becoming critical in 3 to 4 days\n\nVaccination passports cost 70 euros\n\nWidespread public misconceptions\n\nHygiene rules hardly followed\n\nLimited restrictions\n\nLimited mask wearing\n\nOfficial information not believed\n\nIndian summer just now\n\nMoscow may well cope\n\nNew infectious disease hospital\n\nRegions, hospitals already full\n\nMolnupiravir, Merck, awaiting EMU\n\nUS government at $700 (\u00a3515) per course\n\nAnalysts at Harvard School of Public Health and King's College Hospital in London have found it costs just $17.74 (\u00a313) to produce.\n\nDespite this, Merck and Ridgeback could earn $7 billion in profits by the end of the year.\n\nhttps://news.sky.com/story/covid-news-uk-latest-live-experts-discover-why-people-get-covid-toes-as-wales-introduces-vaccine-passports-12425651\n\nhttps://www.fiercepharma.com/pharma/merck-molnupiravir-blockbuster-covid-19-pandemic-endemic-oral-antivirals-market\n\nThat\u2019s about $700 per course. Merck said it expects to make 10 million courses of the drug by the end of 2021, meaning $7 billion in revenue\n\n\n\n\nBBC Media Action\n \n\n\u00a31,569,000 in 2019 - 2020\n\nhttps://www.bbc.co.uk/mediaaction/about/funding\n\nhttps://www.bbc.co.uk/mediaaction/about/annual-reports\n\nhttps://www.bbc.co.uk/mediaaction/where-we-work\n \nWe support the independent media essential to democracy and development. \n\nWe inform, connect and inspire change in our audiences, providing trusted information, stories and ideas that generate discussion and bridge divides.\n\nhelping to save lives and improve health, protect livelihoods, challenge inequality and build more peaceful and democratic societies.\n\nCoronavirus: lessons learned to date \n\nhttps://committees.parliament.uk/publications/7496/documents/78687/default/\n\nin 2020 the UK did significantly worse in terms of covid deaths than many countries\u2014especially compared to those in East Asia\n\nThe UK\u2019s pandemic planning was too narrowly and inflexibly based on a flu model which failed to learn the lessons from SARS, MERS and Ebola. \n\nIn the first three months the strategy reflected official scientific advice to the Government which was accepted and implemented. \n\nWhen the Government moved from the \u2018contain\u2019 stage to the \u2018delay\u2019 stage, \n\nthat approach involved trying to manage the spread of covid through the population rather than to stop it spreading altogether. \n\nThis amounted in practice to accepting that herd immunity by infection was the inevitable outcome, \n\nThe UK, along with many other countries in Europe and North America made a serious early error in adopting this fatalistic approach \n\nand not considering a more emphatic and rigorous approach to stopping the spread of the virus as adopted by many East and South East Asian countries. \n\nThe fact that the UK approach reflected a consensus between official scientific advisers and the Government indicates a degree of groupthink \n\nthat was present at the time which meant we were not as open to approaches being taken elsewhere as we should have been.", "link": "https://www.youtube.com/watch?v=M8SQCDIVf1s", "date_published": "2021-10-13 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]